Progyny (NASDAQ:PGNY) Releases FY 2024 Earnings Guidance

by · The Cerbat Gem

Progyny (NASDAQ:PGNY – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 1.540-1.570 for the period, compared to the consensus estimate of 0.710. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. Progyny also updated its Q4 guidance to $0.07-0.10 EPS.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on PGNY. Canaccord Genuity Group reduced their price objective on shares of Progyny from $24.00 to $18.00 and set a “hold” rating for the company in a research note on Friday, September 20th. JMP Securities cut shares of Progyny from an “outperform” rating to a “market perform” rating in a research note on Thursday, September 19th. Truist Financial cut their target price on shares of Progyny from $33.00 to $26.00 and set a “buy” rating for the company in a research note on Thursday, September 19th. Canaccord Genuity Group cut shares of Progyny from a “buy” rating to a “hold” rating and cut their target price for the company from $37.00 to $24.00 in a research note on Wednesday, August 7th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $25.00 target price on shares of Progyny in a research note on Tuesday, October 1st. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $27.73.

View Our Latest Report on Progyny

Progyny Stock Up 0.7 %

Progyny stock traded up $0.12 on Tuesday, hitting $17.18. The company’s stock had a trading volume of 1,996,870 shares, compared to its average volume of 1,371,571. The firm has a market cap of $1.55 billion, a P/E ratio of 27.27, a price-to-earnings-growth ratio of 1.57 and a beta of 1.44. The company has a fifty day moving average price of $18.01 and a 200-day moving average price of $23.73. Progyny has a one year low of $13.93 and a one year high of $42.08.

About Progyny

(Get Free Report)

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Featured Articles